The current and future healthcare primarily emphasizes the standard guideline-based mental and physical healthcare maintenance, significant enhancement of the quality of life, and deterrence of early and premature morbidity and mortality. Achieving the above global healthcare goals requires novel, affordable, practical, and applicable pharmacological and/or non-pharmacological interventions that must be developed urgently. The discovery and development of new prophylactic and/or therapeutic drugs is a protracted process and can be an exceedingly expensive and unproductive corporate venture and scientific effort.
نظرات کاربران